Researchers at the Harvard Stem Cell Institute may have discovered a way to reverse symptoms of heart failure, a debilitating condition prevalent in old age.
In an ambitious effort to find more personalized treatments for cancer and other complex diseases, Oregon Health & Science University in Portland and Intel are teaming up to develop new computing technologies to map an individual's genetic profile more quickly, precisely and cost-effectively.
Adding to the list of potential treatments scientists hope to derive from embryonic stem cells, researchers at the University of Southampton in the U.K. think new bone repair therapies could be within reach.
Stem cell research with rats may provide hope to stroke victims. In rats, stem cells repaired brain and nerve damage after a stroke, returning the animals to near normal within just a couple of weeks.
Stem cell-based therapeutics are a fast-growing area of early-stage biotech research, but they need better production methods to enable large-scale R&D.
After news of cell transplants making blind mice see, U.S. researchers have used an experimental drug to make deaf mice hear.
A cocktail of genes could repair the damage left behind after a heart attack by reprogramming cells to switch scar tissue back to healthy heart muscle, and also help grow new blood vessels.
San Diego-based Fate Therapeutics has announced that its Wnt protein therapeutic program, in development for use in skeletal muscle regeneration, has moved several steps closer to its goal.
An initiative by scientists at King's College London - Institute of Psychiatry has identified new Alzheimer's drug targets, a finding that could greatly expand efforts to beat back the neurodegenerative disease.
Drug developers may soon have new drug targets for Lou Gehrig's disease, thanks to some promising studies of yeast. Details are highlighted in the journal Nature Genetics .